GC
IDXX icon

Globeflex Capital’s Idexx Laboratories IDXX Stock Holding History

Globeflex Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,900
Closed -$414K – 447
2018
Q2 		$414K Sell
1,900
-200
-10% -$41.2K 0.08% 327
2018
Q1 		$402K Hold
2,100
– – 0.09% 327
2017
Q4 		$328K Hold
2,100
– – 0.09% 268
2017
Q3 		$327K Hold
2,100
– – 0.09% 257
2017
Q2 		$339K Hold
2,100
– – 0.08% 273
2017
Q1 		$325K Hold
2,100
– – 0.08% 312
2016
Q4 		$246K Sell
2,100
-200
-9% -$22.8K 0.06% 334
2016
Q3 		$259K Buy
+2,300
New +$242K 0.06% 315

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Globeflex Capital's IDXX Position: Q3 2018 in Review

Globeflex Capital sold out of Idexx Laboratories (IDXX) in Q3 2018, closing a stake of 1,900 shares — an estimated $414K sold.

Globeflex Capital first reported a position in IDXX in Q3 2016 and held it in 8 quarters. The position peaked at $414K in Q2 2018. 698 funds tracked by Wall St. Rank hold IDXX as of Q3 2018.

  • Globeflex Capital reported no remaining Idexx Laboratories position as of Q3 2018 after selling out during the quarter.
  • Globeflex Capital sold 1,900 Idexx Laboratories shares in Q3 2018, an estimated $414K.
  • Globeflex Capital first reported a position in Idexx Laboratories in Q3 2016 and held it in 8 quarters.
  • Globeflex Capital's Idexx Laboratories position peaked at $414K in Q2 2018.
  • 698 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2018.

Based on Globeflex Capital's 13F filing for Q3 2018, filed 9 Nov 2018.